Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Save the date: BONESUPPORT Capital Markets Days to be held in Stockholm and London

Lund, Sweden, 11:00 CET, 24 August 2018 - BONESUPPORT™, an emerging leader in orthobiologics for the management of bone voids, invites analysts and investors to its Capital Markets Days to take place in Stockholm and London. Capital Markets Days: · 19 September 2018 at 9:00am – 12.00 pm (Stockholm) · 20 September 2018 at 9:30am – 12.30 pm (London) Speakers at the events from BONESUPPORT’s Executive Management Team will be CEO Emil Billbäck, CFO Björn Westberg, Dr Michael Diefenbeck, Head of R&D, Medical and Clinical Affairs and Patrick O’ Donnell, Executive Vice President

Industry frontrunners to collaborate in making ‘green’ propulsion a reality

Wärtsilä Corporation, Trade press release, 24 August 2018 at 12 noon EESTThree of the marine sector’s major technology companies, WinGD, Wärtsilä and GTT, have agreed to collaborate in making the use of LNG (liquified natural gas) fuel a truly viable option for ship owners and operators. By combining their expertise and experience, the three companies deliver an effective, streamlined approach for achieving compliance with environmental legislation. LNG fuel is considered a key enabler of ‘green’ propulsion for ships. It has virtually no sulphur content, produces 80 percent less nitrogen

Active Catena fine-tunes its property portfolio

Following a number of major acquisitions and investments over the year, Catena has also had an active summer with a series of smaller transactions generating conditions for continued growth.24 August 2018, 11:00 a.m.   Catena began the summer with the larger-scale acquisition of Apotea’s warehouse in Morgongåva. Several smaller acquisitions and sales have since been implemented in the second and third quarters.Most recently, on 14 August, Catena sold the company Catena Muskötgatan AB, with the Kroksabeln 17 property in Helsingborg. The transaction was made at an underlying property

Invitation to Gunnebo’s Capital Market Day in Stockholm November 15, 2018

Gunnebo will be holding its Capital Market Day in Stockholm between 08:00 and approximately 13:00 on Thursday November 15, 2018.The day’s programme will provisionally be as follows: · An update on Gunnebo’s strategy · Presentation of Gunnebo’s Business Units · Financial update · Q&A session The CMD, which will be held at Fotografiska, Stadsgårdshamnen 22, Stockholm, will start at 08:00 with registration and breakfast buffet. The programme then starts at 08:30 and will continue until 13:00. The CMD will end with lunch.  If you intend to participate, please send an e-mail

IRRAS AB – Q2 Report 2018 – invitation to conference call and webcast

On Monday August 27, 2018, at 09.00 a.m. CET IRRAS will host a conference call and an online presentation of its Q2 2018 report (which is published the same day at 08.00 a.m. CET).The dial-in numbers for the conference call are: Sweden: +46 8 566 42 662Rest of the world: +44 20 300 89 806The presentation will also be webcast and can be accessed from the following web address: https://financialhearings.com/event/10810Hosts: President CEO Kleanthis G. Xanthopoulos, Ph.D. and CFO and Deputy CEO Fredrik AlpstenInvestor and Media Contact:Fredrik AlpstenCFO and Deputy CEO+46 706

Interim report, January-June 2018

Second quarter in figures  ·  Net sales rose to SEK 1.6 M (0.6) ·  EBITDA amounted to SEK -4.0 M (-4.7) ·  EBIT totalled SEK -4.7 M (-5.1) ·  Loss for the period was SEK -4.7 M (-6.0) ·  Loss per share before and after dilution amounted to SEK -0.52 (-0.67) ·  At 30 June, cash and cash equivalents were SEK 41.6 M (63.3). First half-year in figures  ·  Net sales rose to SEK 3.0 M (1.5) ·  EBITDA amounted to SEK -9.0 M (-7.3) ·  EBIT totalled SEK -10.5 M (-8.0) ·  Loss for the period was SEK -10.5 M (-8.9) ·  Loss per share before and after dilution

Long term contract with Fairfield Industries Inc. for CSV Normand Tonjer

Solstad Farstad ASA (“SOFF”) has entered into a contract with Fairfield Industries Inc. for the CSV “Normand Tonjer”. The contract will commence in 3Q 2018 and has a duration of one year firm plus two yearly options. Fairfield will use the vessel to support their innovative worldwide ocean bottom seismic survey using node-based technology. Skudeneshavn August 24th, 2018 ContactsLars Peder Solstad CEO, at +47 91 31 85 85Anders Hall Jomaas CFO, at +47 40 04 29 18 Solstad Farstad ASAwww.solstadfarstad.com This information is subject of the disclosure requirements according

HiQ and Fortum are building smarter homes

HiQ’s SmartLiving solution helps Fortum’s customers see their environmental impact in an easy-to-understand way.“We wanted to lower the threshold for users by creating an attractive, intuitive, stripped-down design that makes it easy to grasp how behaviour affects energy consumption,” says Magnus Gudéhn, Managing Director at HiQ Stockholm.Users can see their energy and water consumption in real time and can control lighting, alarms and other functions at home through a wall-mounted tablet or mobile app. There are also security features for apartment buildings with push notifications for

Lithuania Upgrades RBS 70 with Night Sight and New Missiles

Saab has received two orders from the Ministry of National Defence Republic of Lithuania for improved missiles and BORC night-capability sights for the RBS 70 system. The order value amounts to approximately SEK 100 million and deliveries are expected to take place starting in 2019.The Lithuanian Armed Forces are already users of the RBS 70 system and are now acquiring improved capability with greater range, higher altitude coverage and an enhanced effect against armored targets as well as night time capability.  “We welcome the decision by the Lithuanian Armed Forces to continue

2cureX AB publishes interim report for the first half-year of 2018

2cureX AB (”2cureX”) hereby publishes the interim report for the first half-year of 2018. The interim report is available via attached file and on the company’s website (www.2curex.com). Below is a short summary of the report.The first half-year (2018-01-01 until 2018-06-30) – the group · Net turnover for the period was 0 KSEK (0 KSEK). · The result after tax was -6 049 KSEK (-2 777 KSEK). · The result per share* was -0,58 SEK (-0,35 SEK). · The solidity** was 47 % (50 %). · The cash and bank was 27 838 KSEK (5 545 KSEK). Second quarter (2018-04-01 till 2018-06-30) – the

Interim report April-June 2018

Vicore Pharma Holding (publ) (ticker: VICO) publish the interim report for the second quarter 2018.Important events during the second quarter · In April, Vicore Pharma received approval to start a Phase IIa study in IPF · In May, Vicore Pharma Holding’s financial asset, I-Tech AB (publ), issued new shares in conjunction with the company’s share listing on Nasdaq First North Important events after the period · In July, Vicore Pharma Holding announced it had entered into an agreement to acquire INIM Pharma AB, a Swedish biopharmaceutical company developing a new local

Europe’s leading iBuyer Kodit.io closes 1.7M€ seed round to fund expansion into new EU cities

Proptech company’s AI-powered real estate platform offers fair prices, quick sales and minimal stress for homeowners looking to sellKodit.io , the Finnish Proptech company that gives homeowners a stress-free way to quickly sell their homes for a fair price, has announced the close of a 1.7M€ seed round to fund expansion into new EU cities. The round was led by Speedinvest x  and Norwegian international media group Schibsted , with Icebreaker.vc providing additional funding. “We are thrilled

H1 2018 report

Financial Highlights Initiator Pharma A/S is a Danish registered company, and is reporting its financial situation in Danish kroner (DKK). Initiator Pharma A/S was registered on May 2, 2016.  +--------------------------------------------+|Second Quarter (2018-04-01 – 2018-06-30) |+--------------------------------------------+| || · Net revenues were TDKK 0 (0) |+--------------------------------------------+| || · EBIT was TDKK -3,294 (-2,023) |+---------------

Interim report, January-June 2018

Second quarter in figures  ·  Net sales rose to SEK 1.6 M (0.6) ·  EBITDA amounted to SEK -4.0 M (-4.7) ·  EBIT totalled SEK -4.7 M (-5.1) ·  Loss for the period was SEK -4.7 M (-6.0) ·  Loss per share before and after dilution amounted to SEK -0.52 (-0.67) ·  At 30 June, cash and cash equivalents were SEK 41.6 M (63.3). First half-year in figures  ·  Net sales rose to SEK 3.0 M (1.5) ·  EBITDA amounted to SEK -9.0 M (-7.3) ·  EBIT totalled SEK -10.5 M (-8.0) ·  Loss for the period was SEK -10.5 M (-8.9) ·  Loss per share before and after dilution

Inteno expands with new software company

Inteno Group AB proudly announces the establishment of a new member in the Inteno group of companies, iopsys software solutions AB. The objective of iopsys software solutions AB is to drive the development and sales of Inteno Group’s enterprise OpenWrt based software platform for gateways, iopsys. To further associate it to iopsys background and origin, the operating system will be renamed iopsysWrt. “By establishing iopsys software solutions we show our commitment to further strengthening the position of iopsysWrt as the premier operating system in the gateway industry” says

Corona Ltd. fined by Dutch gaming authorities

Corona, a subsidiary in the Betsson Group, operating the brands Oranje and Kroon, has received a fine of EUR 300,000 from the Dutch regulator, De Kansspelautoriteit (KSA), for offering gaming to customers in the Netherlands without a local licence. Corona is assessing whether to appeal the decision. Other Betsson entities were also under investigation, but the KSA established that there were no violations with regard to them and no fines were imposed. Betsson AB acquired Corona Ltd in 2014 in anticipation of the re-regulation of the Dutch online gaming market, which according to

ExpreS2ion Biotech Holding AB: Publication of financial report for January – June 2018

ExpreS2ion Biotech Holding AB (“ExpreS2ion”) hereby publishes the financial report for the period of January – June 2018. The report is available as an attached document to this press release and on the Company’s website (www.expres2ionbio.com). Below is a summary of the report.Second quarter (2018-04-01 to 2018-06-30) · Group turnover amounted to 2,982 (2,310)* KSEK · Result after financial items amounted to -4,101 (-3,097) KSEK · Net income amounted to -3,322 (-2,636) KSEK · Net income per share** amounted to -0,28 (-0,30) SEK First half year (2018-01-01 to 2018-06-30)

Immunovia Interim report, January-June 2018

“On 3 April, trading in Immunovia’s shares started on NASDAQ Stockholm’s main market, where we are listed in the Mid Cap segment. During the second quarter we also completed a directed share issue worth around SEK 324 million to reputable institutions in Sweden and internationally. Very exciting results have been achieved in two major application areas, lung cancer and rheumatoid arthritis, which show that the general usability of the IMMray™ platform opens up great opportunities for Immunovia. During the spring and summer we completed a lung cancer study with very good results. This

Smart Eye receives five more design wins from an existing customer

Smart Eye has been awarded five more design wins from an existing customer. It is for additional car models on the same platform where two design wins have already been awarded. The European premium car manufacturer will launch these additional five car models with driver monitoring systems in 2018 and 2019.The order value is estimated to exceed 200 MSEK for the five car models based on product life cycle volume projections. A successful migration of the initial seven cars to subsequent car models for the same platform may lead to a total estimated revenue exceeding 500 MSEK over the

Camanio Care publishes interim report January - June 2018

The complete interim report is available as a pdf-file on our website www.camanio.com and is also attached to this press message.2018-08-24 Pressmessage Camanio Care Interimreport Jan-June 2018 2018-08-24 Pressmessage Camanio Care Interimreport Jan-June 2018  Summary Figures in parentheses refer to the corresponding period during the previous year, unless otherwise is stated.   1 APRIL – 30 JUNE 2018 ·  Total revenue for the period

Registration of merger, de-listing of Oncology Venture from Spotlight Stock Market, last day of trading and record date for the merger

Hoersholm, Denmark, August 24, 2018 – Oncology Venture Sweden AB (“OV”) and Medical Prognosis Institute A/S (now Oncology Venture A/S) (the “Company”) hereby announce, as part of the completion of the previously announced merger between the two companies, that the merger has been registered with the Danish Business Authority and that the Danish Business Authority has notified the Swedish Companies Registration Office (Sw. Bolagsverket) that the legal effects of the merger have commenced. As part of the registration of the merger, the share capital in the Company has been increased to

Panion’s shareholders benefit from CombiGene’s successful funding

The financing of the production development process of CombiGene’s - and therefore also Panion’s - gene therapy product is now secured, according to the press release from CombiGene on 22nd of August 2018. With the unusually large EU-contribution of 3.36 million Euro granted to CombiGene in the Horizon 2020 programme earlier this year and supplemented with the new directed shares emission, which is signed for 75% in advance, the product development is funded and can continue according to plan. It is very positive for Panion’s shareholders that CombiGene has secured the financing of

Invitation to Nokian Tyres’ Capital Markets Day on November 13, 2018

Nokian Tyres plc Press Release August 24, 2018 Nokian Tyres invites analysts and institutional investors to its Capital Markets Day on Tuesday, November 13, 2018. The event will take place in the Helsinki Music Centre (Mannerheimintie 13 A, Helsinki, Finland). The aim of the Capital Markets Day is to provide information on Nokian Tyres’ strategy and business outlook. President and CEO Hille Korhonen and other Nokian Tyres’ representatives will conduct presentations during the afternoon, providing further insights to Nokian Tyres’ strategy and business. The presentation material

There are no items matching the current filter
There are no more items matching the current filter
Back to top